chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Itchy skin and bumps possibly hives. Treated with oral antihistamine(benadryl)
Patient told me that his legs were numb and that he was having difficulty balancing and walking. I took him that afternoon to his pediatrician, who said that his symptoms could be Guillain Barre caused by the flu shot or could just be a normal reaction from the flu shot. His doctor also advised that the symptoms could last a few days but if they worsened to take him to the ER.
felt throbbing  at site of injection; pain at site of shot,felt throbbing yesterday at site of injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (pain at site of shot,felt throbbing yesterday at site of injection) and PAIN (felt throbbing  at site of injection) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, the patient experienced VACCINATION SITE PAIN (pain at site of shot,felt throbbing yesterday at site of injection). On 24-Mar-2021, the patient experienced PAIN (felt throbbing  at site of injection). At the time of the report, VACCINATION SITE PAIN (pain at site of shot,felt throbbing yesterday at site of injection) and PAIN (felt throbbing  at site of injection) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Steroid cream was taken as a concomitant medication for hair. No treatment medication was taken.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient's healthcare providers recommended and/or prescribed ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related injuries. On or about  29-FEB-2012, a pharmacist administered the ZOSTAVAX to the patient (lot number, dosage and route of administration not provided). On or about 2015, the patient was treated by a physician for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events was considered to be not recovered. Additional information has been requested.
SEVERE MUSCLE, NERVE PAIN TO LEFT ARM, STIFF NECK LEFT SIDE, REMAINS AS OF THIS TIME, WILL BE GOING TO DOCTORS FOR FURTHER TESTING, AM NOT ABLE TO USE ARM FULLY WITHOUT EXPERIENCING SEVERE PAIN.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. No information was provided regarding concomitant medications, concurrent conditions or medical history. In 2011, the patient was inoculated with ZOSTAVAX at a clinic as recommended for routine adult health maintenance and for the long-term prevention of shingles (dose, route, and lot # not provided). The vaccine did not prevent shingles as intended and the patient subsequently contracted a persistent strain of herpes zoster or shingles. In 2016, the patient was treated at an urgent care for the onset of a vesicular rash accompanied by weakened immune symptoms which was diagnosed as severe herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. Causality assessment was related. Additional information has been requested.
p/ pt recv vax approx 2yrs later pt exp lesions on rt arm & hand which was described as poison ivy. subsequently dx by MD w/herpes zoster. rpt zoster appeared w/multiple patches of vesicles, sx include decreased appetite & increased sleep.
Could not eat anything; Could not get off toilet because weak; Temperature of 100.6; Achy by the hip; In bed all day sleeping; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (In bed all day sleeping), FEEDING DISORDER (Could not eat anything), ASTHENIA (Could not get off toilet because weak), PYREXIA (Temperature of 100.6) and ARTHRALGIA (Achy by the hip) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 071F21A) for COVID-19 vaccination.     No medication history information was provided.  Previously administered products included for Product used for unknown indication: Johnson and Johnson (Received the Johnson and Johnson regular dose for the primary series in April 2021.) until April 2021. Past adverse reactions to the above products included No adverse event with Johnson and Johnson. Concomitant products included ATENOLOL, AMLODIPINE, FOLIC ACID, LEVOTHYROXINE and SULFASALAZINE for an unknown indication.    On 29-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Nov-2021, the patient experienced SOMNOLENCE (In bed all day sleeping). On 30-Nov-2021, the patient experienced FEEDING DISORDER (Could not eat anything), ASTHENIA (Could not get off toilet because weak), PYREXIA (Temperature of 100.6) and ARTHRALGIA (Achy by the hip). At the time of the report, SOMNOLENCE (In bed all day sleeping), FEEDING DISORDER (Could not eat anything), ASTHENIA (Could not get off toilet because weak), PYREXIA (Temperature of 100.6) and ARTHRALGIA (Achy by the hip) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 30-Nov-2021, Body temperature: 100.6 (High) 100.6.         No treatment medications were provided.  Reporter stated that his daughter also received the vaccine, and did not have any symptoms.
Information has been received from a registered nurse concerning an unknown number of pts who were vaccinated with Hep B vaccine. Subsequently, the pt developed tingling in the arm in which they were vaccinated. This reaction only lasted a short period of time and did not persist in any of the other pts. The pt sought unspecified medical attention. Additional information has been requested.
This spontaneous report was received from a certified medical assistant, concerning a 16 years-old non-pregnant female patient. The patient did not have pertinent medical history, concomitant medications, drug reactions or allergies. On 15-FEB-2017, the patient was vaccinated with the first dose of GARDASIL 9 with lot # M016193 and expiration date on 24-APR-2018 (strength, dose and anatomical location were not reported), administered intramuscularly for HPV prophylaxis; but after that, she had a burning rash around her mouth, that did not completely resolved but its status was improving. The patient did not seek medical attention, no treatment was given for the events and no laboratory diagnostics studies were performed. The relatedness between the oral discomfort and oral mucosal eruption with the vaccine was not reported. No product quality complaint (PQC) was involved. Additional information has been requested.
Pt was given an MMR and Mantoux test. He leaned back in chair, eyes rolled back and had slight jerking of arms became diaphoretic, color yellow, asthen, EMS called. Pt assisted to floor, R 16, 2:08pm BP 116/76 P 76. Pt began to respond 2:10pm fire dept arrived. Mother states no hx of seizures but pt ate nothing today. 2:20pm EMS arrived. BP, P and R, stable. Soda given. Mother ref. transport to hospital. D>C to home with mother after recovery.
Itchy Arm, itch throat, sore throat. swelling throat. Had covid19 shot 1/11/21 with itchy arm and no further reaction.  Vaccination staff RNs and site manager encouraged the patient to see her medical provider and or telehealth ASAP.  Patient discharged alert and oriented with no complaints and verbalized she is doing well, no SOB or respiratory discomfort.  Itchiness has subsided and able to swallow water without complaints.  Discharged with husband.
8/1/12 Pallor, syncopy, jerking motions of upper body, unconscious few seconds x 2 within 30 min. period: tx: layed flat on back x 2 w/feet/legs elevated. BP taken. O2 Sat, HR taken slowly increased and ambulatory after approx 45min. post injection.
Patient said that one week after he received first shingrix he started having muscle pains but he still received 2 nd shot thinking that they are going to get better but he is still having pains all throughout the body even after 6 months and not getting better and the patient is thinking it is from the shingrix shots. He is going to discuss about his with the doctor at the end of the month at his regular visit.
Pale, Weak, broke out in hives all over her body, had a low grade fever...gave her Benadryl every four (4)hours, she was put on Orapred ODT for seven (7) days, by her doctor, taken to the doctors twice, for the hives & itching, they were going away then on 11/14/2009 the hives came back & she is still on the Orapred ODT!
The next day in the morning , I had a headache and my arm felt heavy. Closer to the afternoon I started to feel hot, fever like symptoms, my body was aching. Towards the afternoon was when it was getting worst, I was sweating, I could not hold food down and vomit, my lower body was aching severely it was a struggle to get up and walk. As I attempted to walk I would lose my balance. Towards the night my headaches became sharp migraines on the left temporals it felt like a drill passing through my brain, I couldn't see clearly. I found a small vaginal bleeding and then I ended up with a herpes blister. As I tried to sleep, my chest felt heavy and I started wheezing and my ovary felt as someone was stepping or squeezing on them feeling much pressure and pain. The next morning (today) I did have a rash behind my left ear but it soon went away, I still have that blister, I still have the headache and I am still unable to hold food down as I get nauseous and my body still aches.
Flu-like Symptoms; Cold sweats; Pain; Lethargic; Fever 102 F; Arm swollen; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu-like Symptoms), COLD SWEAT (Cold sweats), PAIN (Pain), LETHARGY (Lethargic) and PYREXIA (Fever 102 F) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 on 02-Jan-2021.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu-like Symptoms), COLD SWEAT (Cold sweats), PAIN (Pain), LETHARGY (Lethargic), PYREXIA (Fever 102 F) and VACCINATION SITE SWELLING (Arm swollen). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN (MOTRIN [IBUPROFEN]) at an unspecified dose and frequency. On 30-Jan-2021, INFLUENZA LIKE ILLNESS (Flu-like Symptoms), COLD SWEAT (Cold sweats), PAIN (Pain), LETHARGY (Lethargic), PYREXIA (Fever 102 F) and VACCINATION SITE SWELLING (Arm swollen) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Jan-2021, SARS-CoV-2 test: positive (Positive) Positive. On 29-Jan-2021, Body temperature: 102 °F (High) 102.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.
ON 1/15 LEFT ARM DISCOLORATION (SKIN DARKENED). SWELLING AND REDNESS AROUND INJECTION SITE. DULL PAIN LINGERING 3 DAYS (SCALE 4/10). SHIVERING AND CLAMMY SKIN.
Onset of joint pain 4/13/03, until present. Intense pain, edema especially of knees. Using celebrex and ibprofon
Trouble breathing, heart rate really high then would drop really low, had a full blown asthma attack, had to go get nebulizer treatment, inhaler and steroids. Was put on heart monitor, had heart sonogram, EKG.  Heart rate is still messed up.
Redness and swelling of cheeks. Face feeling hot to the touch. Redness of neck. Took benedryl, ibuprofen and omeprazole and symptoms went away in a few hours.
Pain and inflammation around injection site starting two week after first vaccination, patient did not alert healthcare professional when received second dose, patient reported adverse event today 11/26/2021.
Large red swollen rash near injection site. Started small about eight hours after injection and continue to grow for four days following.
Pt had swelling to tongue, lower lip and hives one day after vaccine #2 given 4/22/21, symptoms started 4/23/21.  VAccine was received at pharmacy.
pt recvd MMR/OPV/HIB on 3JUL91 & immed following vax pt devel erythema approx 5 cms in diameter; pt was treated w/unspecified antihistamine & cold pack & recovered;
Approximately 1 minute after vaccination patients left arm began shaking and patient lost ability to communicate and control wheel chair. Still sat in chair but non-communicative, non directive/directable.  After about 45 sec patient arm movement stopped and patient able to respond.  Somnolent after event. No loss of continence. No memory of event.
CRPS (Complex Region Pain Syndrome) flare up; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of COMPLEX REGIONAL PAIN SYNDROME (CRPS (Complex Region Pain Syndrome) flare up) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     No medical history information was reported.  Concomitant products included GABAPENTIN, ACETYLSALICYLIC ACID (BABY ASPIRIN), TOPIRAMATE, HYDROXYZINE, LISINOPRIL, METHOCARBAMOL and TIZANIDINE HYDROCHLORIDE (ZANAFLEX) for an unknown indication.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced COMPLEX REGIONAL PAIN SYNDROME (CRPS (Complex Region Pain Syndrome) flare up). At the time of the report, COMPLEX REGIONAL PAIN SYNDROME (CRPS (Complex Region Pain Syndrome) flare up) was resolving. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment for the event included unspecified oral steroids.
Psychological episode, non stop screaming and crying as if she was in severe pain, arching of body. Turning red and purple. Took her to the ER was giving 5ml ibuprofen 5ml acetaminophen.
Within 8 mins I got short of breath felt dizzy, tunnel vision, then tongue and throat started feeling full of swollen. HR was 115, respiration?s 28, B/P 169/72 02 sats 99% initially but dropped to 94%.
Patient presented to emergency department with complaint of shortness of breath.  She tested positive for covid 19 on 10/27, patient received monoclonal antibodies on 11/2, her saturation dropped to 84% on room air on 11/3.  In ER patient was mildly hypotensive with blood pressure of 95/53, initially patient was maintaining saturation 94% room air, and she dropped with minimal exertion.. Chest x-ray obtained did not reveal any consolidations or infiltrates.  Patient was started on dexamethasone, zinc, vitamin supplements, doxycycline.  Her symptoms improved, she is maintaining more than 92% on room air.   Patient  became hemodynamically stable, she was discharged home today, he should come to continue taking dexamethasone to completed 10 day course, and doxycycline antibiotics.
Patient was given two dose series of Moderna vaccine and is under the age of 18. This was an administration error, and I was advised to report to VAERS. No adverse effects or events were reported. Patient was contacted
99.5oF; nonstop headache; severe night sweats; abdomen feels like I have diverticulitis; abdominal pain; poor appetite; semi-loose stools; disrupted my life and routine; This case was reported by a consumer via call center representative and described the occurrence of diverticulitis in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On 13th July 2022, the patient received the 1st dose of Shingrix. On 14th July 2022, 1 days after receiving Shingrix, the patient experienced headache and fever. In July 2022, the patient experienced diverticulitis (serious criteria GSK medically significant), sweating, abdominal pain, appetite lost, loose stools and activities of daily living impaired. On 16th July 2022, the outcome of the fever was recovered/resolved. On an unknown date, the outcome of the diverticulitis, headache, sweating, abdominal pain, appetite lost and loose stools were not recovered/not resolved and the outcome of the activities of daily living impaired was unknown.   It was unknown if the reporter considered the diverticulitis, headache, sweating, fever, abdominal pain, appetite lost, loose stools and activities of daily living impaired to be related to Shingrix.     Additional Information: GSK Receipt Date: 16-JUL-2022  Reporter's Comments: This case was self-reported by patient. The patient received first dose of Shingrix vaccine on last Wednesday (before reporting) and today (on the day of reporting) was Saturday and the patient experienced nonstop headache since Thursday (before reporting) morning. The patient reported that Thursday and Friday night, less than a week the patient got up twice to change clothes and beds due to severe night sweats and the patient's abdomen felt like had diverticulitis for the first time in many years. The patient ran a fever of about 99.5 Degree Fahrenheit Thursday afternoon till Saturday morning (on the day of reporting).  The patient read that these were normal side effects.  The patient asked when patient should begin to see these side effects lessen and what was the average length of time for night sweats, headache, abdominal pain, poor appetite and semi-loose stools. The patient reported that this dose had severely disrupted patient's life and routine, so the patient would like to know when the patient might start feeling better as shown in the statistics GlaxoSmithKline collect.  The patient was just seeking the average recovery time for these symptoms.
Chills; shakes; loss of apetite; middle back hurt; sore arm; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 05-Feb-2021 and was forwarded to Moderna on 06-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), TREMOR (shakes), DECREASED APPETITE (loss of apetite), BACK PAIN (middle back hurt) and PAIN IN EXTREMITY (sore arm) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension. Concomitant products included PARACETAMOL (TYLENOL), CAFFEINE, PARACETAMOL (EXCEDRIN ASPIRIN FREE), LOSARTAN and LEVOTHYROXINE for an unknown indication.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Jan-2021, the patient experienced BACK PAIN (middle back hurt) and PAIN IN EXTREMITY (sore arm). On 03-Feb-2021, the patient experienced CHILLS (Chills), TREMOR (shakes) and DECREASED APPETITE (loss of apetite). At the time of the report, CHILLS (Chills), TREMOR (shakes), DECREASED APPETITE (loss of apetite), BACK PAIN (middle back hurt) and PAIN IN EXTREMITY (sore arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Patient took Tylenol and Excedrin
24 hrs p/immun, pt w/hx of sz disorder devel fever of 101 & sz; Pt had sz in past following DTP immun;
Welts appeared around injection site approximately 12 hours after vaccination and have remained for 36 hours. The welts were in 2 major patches within 5 inches of the injection site and were approximately half-dollar sized. They are painful and tender.
Fainting 15 minutes after vaccine.  Consciousness loss, fall, extreme weakness for  several days. Extreme headache for over 2 weeks and lingering over 4 weeks.
Wrong lot number ( see error on med sheet) original Hep B number was documented in wrong spot then inadventally correct vaccine was given.
Received the first dose on 4/7/21 at 3:30 pm, no adverse affects. Received the second dose on 4/28/21 at 3:30pm, only a sore arm for the first 24 hours. At about 3:30pm on 4/29/21, began to feel a tightness in the chest, took my inhaler and it provided slight relief. At 3:30am on 4/29/21, throat began to swell so I went to the ER to get that checked out. They gave me Benadryl, a steroid shot, and some Pepcid for anti-inflammatory and provided prescriptions for when the medicines they administered wore off. From 5/1/21 until today, I have felt slight swelling in the throat and mouth and sinus areas, all manageable by prescriptions given. Today, 5/3/21, felt fatigue and headaches. There is still a bruise at the sight of injection, but no swelling there.
31 year old male presented to the administrative medicine clinic for a primary care intake exam with PMH significant for hearing loss, astigmatism and sciatica. Patient reported no known drug allergies upon intake. Patient was administered pneumococcal conjugate vaccine (0.5 mL; Left deltoid; Man: Wyeth; Exp: 2/17; Lot # : L99273) at approximately 1130 on 12/18/15. Patient reported no symptoms upon initial administration. Patient phone clinic on 12/22/15 to report worsening erythema and induration to triage nurse. Patient advised to report to clinic 12/23/15 where localized erythema and induration were documented, systemic symptoms including swelling, anaphylaxis, and hives were notably absent. Patient was prescribed a methylprednisolone taper and advised to contact EMS/911 should symptoms worsen or fail to improve. Patient lost to follow-up thereafter.